A Multicentre Feasibility Study of Online Adaptive Image Guided Radiotherapy for Muscle Invasive Bladder Cancer
This is a single-arm multicentre feasibility trial in which the primary aim is to determine
the compliance rate of patients to online adaptive radiotherapy for muscle invasive bladder
cancer over multiple Australian and New Zealand centres. The compliance rate is defined as
the proportion of patients successfully completing treatment without a major protocol
deviation.
Subject to the accrual being at least 40 patients in the first 2 years, accrual will
continue until a total of 50 patients have been accrued. If this accrual target is not met,
then consideration will be given to stopping the trial early due to poor accrual. Each
patient will be followed-up until 2 years after the last patient's date of accrual.
Assessments for toxicity and recurrence or progression will take place at four weeks after
completion of treatment, then three monthly from the end of treatment for the first 12
months and then 6 monthly thereafter.
Interventional
Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
Compliance with Online Adaptive Radiation Therapy process
A patient is considered to be compliant if that patient completes treatment without experiencing a major protocol deviation
From the start date of radiotherapy to the last day of radiotherapy treatment (approxiamately 6 weeks and 2 days)
No
Dr Farshad Foroudi
Study Chair
Peter MacCallum Cancer Centre, Australia
Australia: Human Research Ethics Committee
TROG 10.01
NCT01142102
October 2010
June 2015
Name | Location |
---|